Response to Stephane Renaud et al

Radiother Oncol. 2018 Oct;129(1):188-189. doi: 10.1016/j.radonc.2017.12.001. Epub 2017 Dec 26.

Authors

Wen-Chi Yang¹, Jin-Yuan Shih², Chao-Chi Ho², Feng-Ming Hsu³

Affiliations

¹ Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
² Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
³ Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: hsufengming@ntuh.gov.tw.

PMID: 29287737
DOI: 10.1016/j.radonc.2017.12.001

No abstract available

Publication types

Letter
Comment

MeSH terms

Brain Neoplasms*
Carcinoma, Non-Small-Cell Lung*
ErbB Receptors
Humans
Lung Neoplasms*
Mutation
Radiosurgery*

Substances

ErbB Receptors